Maternal microchimerism (MMc) has been associated with development of allospecific transplant tolerance, antitumor immunity, and cross-generational reproductive fitness, but its mode of action is unknown. We found in a murine model that MMc caused exposure to the noninherited maternal antigens in all offspring, but in some, MMc magnitude was enough to cause membrane alloantigen acquisition (mAAQ; "cross-dressing") of host dendritic cells (DCs). Extracellular vesicle (EV)-enriched serum fractions from mAAQ + , but not from non-mAAQ, mice reproduced the DC crossdressing phenomenon in vitro. In vivo, mAAQ was associated with increased expression of immune modulators PD-L1 (programmed death-ligand 1) and CD86 by myeloid DCs (mDCs) and decreased presentation of allopeptide+self-MHC complexes, along with increased PD-L1, on plasmacytoid DCs (pDCs). Remarkably, both serum EV-enriched fractions and membrane microdomains containing the acquired MHC alloantigens included CD86, but completely excluded PD-L1. In contrast, EV-enriched fractions and microdomains containing allopeptide+self-MHC did not exclude PD-L1. Adoptive transfer of allospecific transgenic CD4 T cells revealed a "split tolerance" status in mAAQ + mice: T cells recognizing intact acquired MHC alloantigens proliferated, whereas those responding to allopeptide+self-MHC did not. Using isolated pDCs and mDCs for in vitro culture with allopeptide+self-MHC-specific CD4 T cells, we could replicate their normal activation in non-mAAQ mice, and PD-L1-dependent anergy in mAAQ + hosts. We propose that EVs provide a physiologic link between microchimerism and split tolerance, with implications for tumor immunity, transplantation, autoimmunity, and reproductive success. 
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dendritic cells | exosomes | split tolerance | T cells | microchimerism I mmunologic tolerance was originally described in 1945 as a state of 50:50 mixed chimerism in dizygotic bovine twins (1), a discovery that launched modern immunogenetics and remains the gold standard for organ transplantation tolerance (2) . Conversely, maternal microchimerism (MMc), common to all mammals, imposes a partial form of immunologic tolerance. Female offspring gain cross-generational fitness in the form of acquired resistance to loss of a fetus bearing inherited paternal antigens (IPAs) identical to her noninherited maternal antigens (NIMAs) (3, 4) . MMc also has a strong impact in transplantation. Significantly longer graft and patient survival is achieved under a standard immunosuppressive regimen in recipients of a sibling kidney or bone marrow transplant that expresses the NIMA haplotype as the HLA mismatch (5, 6) .
Paradoxically, NIMA + sibling kidney transplants had a significant increase in early acute rejection episodes, followed by comparative freedom from late graft loss, compared with sibling transplants mismatched for noninherited paternal antigens (5) . The basis for such conflicting manifestations of preexisting MMc is that such tolerance is split. The indirect allorecognition pathway, whereby host antigen-presenting cells (APCs) present processed allopeptides bound to self-MHC-II (major histocompatibility complex) molecules to CD4 Th cells (7), is anergic or suppressed (8) (9) (10) . In contrast, conventional allorecognition of maternal target cells by T cells in adults (known as direct alloreactivity) is intact (11, 12) . The latter seems to be largely responsible for early acute rejection of organ transplants (13) . Curiously, the persistence of exposure to certain NIMA-HLA may lead to increased or decreased risk of certain rheumatoid diseases (e.g., rheumatoid arthritis) depending on the NIMA-HLA haplotype (14, 15).
The transfer of membrane-bound intact allo-MHC molecules from the allogeneic cell to host dendritic cells (DCs) has been described (16) . This membrane alloantigen acquisition (mAAQ), also known as cross-dressing (17) , can occur by extracellular vesicle (EV) exchange. Importantly, mAAQ gives rise to a subset of host DCs that express intact allo-MHC molecules on the cell surface, while also presenting processed allopeptides, thus allowing a single DC to interact with both directly alloreactive CD8 + cytotoxic T lymphocytes and indirect pathway CD4 + Th cells (16) (18) . This process has recently been shown to be critical to a direct pathway, acute rejection response in organ transplantation (19, 20) . Furthermore, because certain EVs, like exosomes, contain microRNAs (miRNAs), acquisition leads not only to surface expression of intact transferred allo-MHC/peptide complexes, but can also change the functional status of the mAAQ + DC (21) .
Significance
The induction of tolerance is still an ideal and largely unachieved goal in the transplantation and autoimmunity fields. Understanding natural allotolerance mechanisms could help realize this objective. In this study we found that maternal microchimerism generated "split" tolerance, stimulating classical alloreactivity (i.e., recognition of intact peptide/allo-MHC class II complexes by CD4 T cells), while silencing CD4 T cells responding to allopeptide in a self-MHC-restricted manner. These contrary activities could be attributed to the presence of separate antigenic microdomains with different costimulatory properties on the surface of a single host dendritic cell. The possibility that this state develops from interaction with a microchimerism-derived extracellular vesicle has important implications for cell biology, cancer immunotherapy, and molecular immunology.
Here, we used a mouse model to determine whether the amplification mechanism of MMc and the split nature of the tolerance it induces might be consequences of functional changes in host DCs caused by EV acquisition from rare maternal cells.
Results
Maternal (Fig. 1B and Fig.  S1 ). The incidence of mAAQ + status in NIMA d mice was 45% (31/68), similar in males and females. In adult mAAQ + offspring, the proportion of H2K d-dim DC was quite variable (range 1-25%; mean ± SD = 5.32 ± 5.84%) and was detectable on fresh myeloid DCs (mDCs), but no other subpopulations (Fig. S1 ). Using imaging flow cytometry, we found that splenic mAAQ + mDCs could be clearly distinguished by an uneven punctate/patchy surface distribution of H2K d staining ( Fig. 1 B and C), whereas freshly isolated plasmacytoid DCs (pDCs) did not show any evidence of mAAQ (Fig. 1D ).
Serum (EV)-Enriched Fractions Replicate the mAAQ Phenomenon in
Vitro. EV-enriched serum fractions from non-mAAQ and mAAQ + mice were obtained by using various approaches (Materials and Methods). Fig. S2 shows the characterization of EV-enriched fractions obtained using matrix precipitation. EV-enriched serum fractions from individual mice were cultured with C57BL/6 splenocytes to determine whether they could generate mAAQ. C57BL/6-and BDF1-derived serum EV were used as negative and positive controls, respectively.
EV fractions from mAAQ + mice induced acquisition of H2K d and IA d on both mDCs and pDCs between 6 and 24 h of culture ( Fig. 1 E and F shows the 6-h data). Conversely, EV fractions from non-mAAQ mice induced neither K d nor IA d acquisition by C57BL/6 splenocytes; results were no different from the negligible mAAQ signal (background) detected after incubation with control C57BL/6-derived EV (Fig. 1G) . Thus, serum EV-enriched fractions from non-mAAQ vs. mAAQ + mice were significantly different in their ability to cause appearance of MHC-I and -II intact alloantigens on the surface of both pDCs and mDCs.
The mDC >> pDC bias of mAAQ noted in vivo did not appear to arise from differences in ability to reexpress intact H2K (Fig. 1E) . In contrast, B6 pDCs displayed both alloantigens evenly, with no retained EVs at this time point (Fig. 1F) . The more rapid EV uptake and reexpression of allo-MHC (particularly I-A d ) by pDCs was transient compared with mDCs, on which mAAQ continued to increase up to 12 h and stabilized at 24 h (Fig. S3) .
To investigate further the forms of NIMA d in serum of nonmAAQ vs. mAAQ + mice, we analyzed 100,000 × g ultracentrifuged fractions of serum by ELISA (Materials and Methods). As expected because of a mutation in the Eα locus in H-2 b strains, B6 serum was completely negative for I-E antigen (Fig. 1H ), , NIMA d backcross mouse, the only source of I-E would be rare BDF 1 (maternal) cells. Surprisingly, a strong I-E signal was detected in serum from non-mAAQ NIMA d mice, but only in the EV-free fraction (Fig. 1H) . In mAAQ + mouse serum, we detected I-E in both EV-free and EV-enriched fractions of serum, indicating that maternally derived MHC-II + cells had generated both membrane-bound and free soluble forms of alloantigen. The ELISA data are thus consistent with the in vitro mAAQ data, and with quantitative PCR (qPCR) analysis of bone marrow MMc (see Microchimerism Analysis) that reinforce the idea that, although all NIMA d offspring have some MMc and are chronically exposed to maternal soluble MHC, only mAAQ + mice have sufficient MMc to generate EVs capable of cross-dressing host APCs. 
Analysis of DC, Serum EV, and EV-Free Fractions for Patterns of PD-L1
and CD86 Coexpression. To determine whether cross-dressing had altered the DCs of mAAQ + mice in either (i) the pattern of costimulatory molecule expression or (ii) the expression of allopeptide/self-MHC-II complexes, those features were analyzed in freshly isolated splenocytes. By comparing the H2K Fig. 2A) . CD11b expression remained unchanged.
Although a H2K d-dim subset was not discernible in fresh pDCs ( Fig. 1 D and F and Fig. S1 ), PD-L1 expression was significantly increased overall on pDCs of mAAQ + vs. non-mAAQ mice (Fig.  2B) . The pDCs from mAAQ + mice showed a significantly reduced expression of the Eα 52-68 peptide-IA b complex recognized by the YAe monoclonal antibody (hereafter referred to as the "YAe epitope"), compared with pDCs of non-mAAQ mice ( Fig.  2B and Fig. S4 ).
To further characterize the serum EV fractions, we analyzed them by immunoprecipitation, SDS/PAGE, and Western blot. As shown in Fig. 2C , EV-enriched serum fractions from both mAAQ + and non-mAAQ NIMA d mice, like EV from BDF 1 , contained the exosome-associated tetraspanin CD9, as noted by imaging flow cytometry and Western blot (Fig. S2) . Total EV derived from mAAQ + mouse serum and from non-mAAQ mice had abundant PD-L1 and CD86 (Fig. 2C, lanes 2 and 3) , as did control BDF 1 EV (lane 1). However, when serum EV fractions were enriched for YAe (Fig. 2C , lanes 4 and 5) or H-2K d expression (lanes 6 and 7), differences in costimulatory molecule expression emerged. The YAe-enriched EV fraction from mAAQ + and non-mAAQ mouse serum contained both CD86 and PD-L1. However, the H2K d -enriched fraction of mAAQ + EV contained CD86, but not PD-L1 (Fig. 2C, lane 7) . H2K d enrichment of EV fractions from non-mAAQ mouse serum produced no signal for either CD86 or PD-L1. Together, these data suggest that mAAQ was associated with cotransfer of CD86 along with class I and II allo-MHCs. Unlike CD86, PD-L1 expression in the mAAQ + DCs did not appear to arise from EV protein transfer, suggesting an induction of endogenous PD-L1 expression by another component of the EV.
Microchimerism Analysis. In a group of eight NIMA d mice, all but one had some level of MMc in bone marrow detectable by qPCR assay. A linear correlation between the MMc level and the proportion of mAAQ + mDCs (r = 0.81, P = 0.01) was observed (Fig. S5A) . These data are consistent with the ELISA results for serum I-E (Fig. 1H) (Fig. 3A) , similar to that seen after in vitro coculture of splenocytes with EV fractions (Fig. 1) . CD86 was also colocalized with the mAAQ patches on the mDC (Fig.  3D) . However, H2K d and IA d were not colocalized with PD-L1, which appeared to be completely excluded from the mAAQ patches (Fig. 3B, blue arrow) .
On mDCs of mAAQ + mice, PD-L1 was mostly excluded from areas where the YAe epitope was expressed. Nevertheless, there was a significantly higher YAe/PD-L1 colocalization (BSI) value compared with H2K d /PD-L1 (P < 0.001; Fig. 3 B and C) . On pDCs, the YAe epitope was even more colocalized with PD-L1, with some values of BSI in the 1-2 range (Fig. 3E) . These data, along with the presence of PD-L1 in YAe-enriched EV of mAAQ + mice and its absence in H2-K d -enriched EV that contain CD86 (Fig. 2C) , strongly suggest a difference in the costimulatory context of cross-dressed vs. endogenously processed alloantigen.
To better visualize the PD-L1 context of YAe epitopes arising from the classical MHC-II processing and presentation pathway of the host, we used B6 recipients of a DBA/2 (YAe neg ) heart allograft, made tolerant by anti-CD40L treatment. In this fully allogeneic tolerance setting, in which all YAe expression derives from the classical MHC-II pathway and none from cross-dressing, we found that PD-L1 was highly colocalized with the YAe epitope on the surface membrane of splenic mDC (Fig. S6) . (Fig. 4 A-C) .
To interrogate the indirect allorecognition pathway, CFSElabeled TEa cells, CD4 T cells that express a TcR specific for the YAe epitope, were adoptively transferred. No proliferation was seen in negative control B6 mice, whereas in BDF1 mice, all transferred TEa cells proliferated. A substantial portion of TEa cells proliferated in non-mAAQ mice. In contrast, within mAAQ + mice, no productive proliferation of TEa cells occurred (Fig. 4 D  and E) . Instead, TEa cells in mAAQ + hosts underwent abortive activation based on two criteria: (i) Cell-cycle analysis indicated that up to 80% of the TEa cells in the mAAQ + recipient underwent one division cycle, whereas only a negligible proportion (<1%) underwent further proliferation (Fig. 4D and Fig. S7A) ; and (ii) despite arrest after one cell division, there was a significant increase of activated phenotype (Fig. S7 B and C) . By contrast, 4C T cells that failed to proliferate after transfer into non-mAAQ hosts retained a naïve phenotype (Fig. S7 D and E) . The split-tolerance phenomenon was reflected in prolonged transplantation survival in some, but not all, mAAQ + vs. nonmAAQ recipients of DBA/2 heart allografts ( Fig. S5B) . Both T-cell adoptive transfer and allograft studies suggested that the impact of MMc on host DCs could result in either (i) no restraint on alloreactivity, with strong TEa proliferation and uniform acute rejection of heart allografts in non-mAAQ mice; or (ii) split tolerance, with TEa abortive activation coupled with 4C proliferation and acute rejection or long-term DBA/2 heart allograft survival in untreated mAAQ + mice. The latter results are consistent with the cardinal feature of split tolerance (i.e., a premature and weakened, but still active acute rejection pathway, followed by a relative freedom from chronic rejection) (5, 22) .
In Vitro Analysis of Alloantigen Presentation-The PD-L1 Basis of Split
Tolerance. To determine whether the observed costimulatory/ coinhibitory patterns on DCs were relevant to the mechanism of the split-tolerance condition, mDCs and pDCs were sorted from NIMA d mice and controls (C57BL/6 or BDF1) and cultured with either 4C or TEa cells, in the presence or absence of anti-PD-L1 antibody (Fig. 4F summarizes two independent experiments, two replicates each).
Whereas neither mDCs nor pDCs isolated from non-mAAQ mice stimulated proliferation of 4C T cells, both DC types induced TEa proliferation. The addition of anti-PD-L1 antibody to the TEa-non-mAAQ DC cultures had no effect on proliferation of the TEa cells.
In contrast, when mAAQ + mice were used as the source of DCs for coculture, we observed opposite results, thus resembling the in vivo assay (Fig. 4 A-E) . The mDCs from mAAQ + mice induced proliferation of cocultured 4C T cells. In contrast, neither DC subset in mAAQ + mice was able to stimulate TEa proliferation. However, PD-L1 blockade restored TEa proliferation: the levels of CFSE low TEa cells observed in the presence of anti-PD-L1 antibody strongly supported the role of PD-L1 in anergy/abortive activation of indirect recognition in mAAQ + settings (Fig. 4E and Fig. S8 A and B) . Finally, titration experiments were performed with variable ratios of BDF1:C57BL6 DCs for both mDCs and pDCs. The 4C cells did not proliferate below a 1:100 BDF1:C57BL/6 DCs ratio (Fig. S8C) . These results strongly suggest that 4C proliferation induced by DCs from mAAQ + mice represents T-cell interaction with cross-dressed host DCs, rather than direct allorecognition of the rare maternal DCs themselves.
Discussion
Low numbers of maternal cells persist in the offspring of placental mammals after birth. How such rare cells go on to mediate a tolerogenic impact on later fetal survival in adult female hosts (3, 4) and on transplant survival in males and females (5, 6, 23, 24) , while causing an increased tempo of acute rejection episodes (5), has been a major conundrum. 
Proposed Model for Rare Cell Amplification and Split Tolerance in
Microchimerism. Fig. 5 shows two hypothetical forms of MMc that could explain our results. Both models assume that DCs acquire peptide/MHC-II complexes by two distinct mechanisms, represented by opposite sides of the dotted lines in Fig. 5 . One is classical MHC-II antigen presentation: Engulfed and processed exogenous antigens are recognized as peptides by CD4 T cells in a MHC-II-restricted manner (right sides of lines). The other is nonclassical: cross-dressing or acquisition of EVs (such as exosomes) containing intact peptide/MHC complexes from another cell source. This latter form of antigen presentation has recently been shown to be the cause of acute rejection of allografts, by greatly amplifying the impact of donor passenger leukocytes (19, 20) .
In the non-mAAQ host (Fig. 5A) , MMc is depicted as a tissueresident, MHC-II + cell capable of producing only a soluble form of the MHC-II alloantigen I-E d (Fig. 1H) . This I-E is processed and presented as Eα 52-68 /I-A b complexes, leading to YAe expression by DCs. Engagement of peptide-MHC occurs in the context of CD80 or CD86, so a responding T cell can form productive TCR/CD28 signaling complexes (25) . In this low MMc condition (Fig. S5A) , EVs are produced by host-type DC (Fig. 5A, Upper) , not by maternal cells. The YAe epitope is packaged in EVs with a high CD86:PD-L1 ratio (Fig. 2B) . Thus, the cross-dressing pathway reinforces a positive costimulation context for the TEa responder cell. However, the 4C T cell is left unstimulated.
In contrast, in the mAAQ + host, MMc produces both soluble and EV-associated antigens (Figs. 1H and 5B). DCs are known to generate EVs capable of inducing transplant tolerance (26) , but other MHC-II + cellular subsets cannot be ruled out as EV sources. However, one can distinguish tolerant from graft-rejecter NIMA d mice by MMc presence in CD11c and CD11b lineages (27) , implicating a myeloid cell. Because EVs derived from rare maternal cells (H2-K d+ ) had CD86, but lacked PD-L1 (Fig. 2B) , we propose that CD86-rich microdomains containing crossdressed allo-MHC are formed on the DC surface. This formation of CD86/allo-MHC-enriched microdomains allows productive TCR/CD28 complexes to form on the 4C CD4 T cells, causing their proliferation. Remarkably, other microdomains formed on the same host DCs become enriched in PD-L1 (Figs. 3 and 5B). Antigens presented in these regions would be likely to induce TcR signaling in microclusters with PD-1, abrogating effective stimulation (28) . Because PD-L1 is not coming from protein expressed by the MMc-derived EVs (Fig. 2B) , we suggest an alternative possibility (indicated by ? in Fig. 5B ): that exosomal RNA causes a functional reprogramming of the MHC-II/classical presentation pathway. The result is that endogenous PD-L1 is expressed in the same microdomains as Eα 53-68 /I-A b complexes at the DC surface. An example of miRNA-based regulation controlling PD-L1 expression in mDCs has recently been reported (29) . The observation of a stronger signal for PD-L1 on the Western blot of YAeenriched serum EV fraction from mAAQ + mice (Fig. 2B) suggests that the nonclassical cross-dressing pathway (Fig. 5B, Upper Left) has also been altered, increasing the PD-L1/CD86 ratio and further colocalizing the YAe epitope with PD-L1 (Fig. 3) . Formation of PD-L1-poor and PD-L1-rich microdomains on DCs, along with lower expression of Eα 53-68 /I-A b complexes (Fig. 2B) , could account for productive stimulation of 4C, but abortive activation and anergy of TEa cells (red X, Fig. 5B ).
Split Tolerance and NIMA Effect. One important caveat in our study is that only one mouse strain combination (B6 -H2 b , DBA/2-H2 d ) has been analyzed. Thus, it is possible that an EV-based mechanism for rare signal amplification and differential costimulation of T effector cells, leading to split tolerance, applies only to this particular mouse breeding model. However, there is reason to believe that such a mechanism is widely applicable. In a different mouse breeding combination, Akiyama et al. (30) showed that directly alloreactive CD8 TcR Tg T cells were not inhibited by NIMA class I exposure; instead, K b -exposed H2 k mice were tolerized at the level of allopeptide-specific CD4 Th cells, consistent with split tolerance (30) .
The finding of Kinder et al. (4) , that MMc-induced Treg development impacts cross-generational reproductive fitness via NIMA-specific Tregs in female offspring, appears to conflict with the results of Molitor-Dart et al. (24) showing increased likelihood of acute rejection in female vs. male recipients of NIMA + heart allografts. However, a higher level of MMc in females, and the presence of intrauterine MMc in particular (4), may enhance development of allopeptide-specific Tregs, but at a cost of a stronger semidirect pathway, responsible for a higher acute rejection risk in an immunosuppressive-free model of organ transplantation (24) . Indeed, mammalian pregnancy requires an acute inflammatory response to facilitate embryo implantation, while chronic regulation of the maternal immune response during gestation protects against fetal loss (31) . In this way, split tolerance to NIMA may be the best way to enforce cross-generational fitness (4).
Our results, together with those of Kinder et al. (4) , help to explain the original observations of split tolerance to NIMA-Rh by Owen et al. (3) . Indeed, the claim leveled against Owen's hypothesis was that, rather than tolerizing the daughter to a subsequent fetal antigen, NIMA exposure had sensitized her (32) . This apparent contradiction may now finally be resolved, because, at the cell surface of the MMc-modified, mAAQ + DCs, both sensitizing and tolerizing forms of NIMA presentation can be found side by side. The contrasting impact of functional, CD86-associated, and nonfunctional, PD-L1-associated, microdomains may explain why host B-cell responses were historically the first to be described as suppressed by exposure to maternal noninherited antigens, because IgG responses such as those to Rh (3) or HLA (33) are strictly dependent on Th cells, triggered by the classical pathway of peptide/MHC-II generation and antigen presentation (34) . Our findings may be relevant to other contexts: for example, the antileukemia effect of cord blood transplants when the recipient is mismatched for a NIMA (35) or shares an IPA (36) and the breaking of split tolerance to tumor antigens by PD1/PD-L1 blockade (37) .
Materials and Methods
Mice. The 8-to 12-wk-old C57BL/6, BDF1 (Harlan), TEa TCR Tg [B6.Cg-Tg(Tcra, Tcrb)3Ayr/J; Jax catalog no. 005655], 4C TCR Tg (Duke University), and C57BL/6 CD90.1 (B6.PL-Thy1a/CyJ; Jax catalog no. 000406) mice were used. All studies with mice were performed in accordance with NIH vertebrate animals guidelines, and approved by the University of Wisconsin-Madison Institutional Animal Care and Use Committee (IACUC).
Serum EV Enrichment. An exosome-isolation kit (Invitrogen, catalog no. 4478360) was used for serum EV enrichment, plus final ultrafiltration (0.45 μm).
In experiments for ELISA analysis, the ultrafiltration method was used (SI Materials and Methods).
Flow Cytometry Imaging (ImageStream). Antibodies and procedures for flow cytometry imaging are listed in SI Materials and Methods. Acquisition was made with BD LSR-II and ImageStream MKII Amnis (60×). Data analysis was performed by using FlowJo (Version 7.6.5 or 10) and Ideas.
Surgical Procedures. Hemisplenectomies and heterotopic heart transplants were performed as described in Dutta et al. (9) .
Cell Sorting. For cell sorting, magnetic beads technology was used (Miltenyi and StemCell Technologies, QuadraMACS and PurpleMagnet).
Adoptive Transfer Experiments (in Vivo MLR). Hemisplenectomy was performed in mice, and splenocytes used to determine mAAQ status. Seven days later, mice were i.v.-injected (retroorbital) with 10-15 × 10 6 CFSE-labeled TCR Tg CD4 T cells. At 72 h after the injection, TCR Tg cell proliferation was addressed with the CFSE-dilution method (splenocytes).
TCR Tg CD4 T Cell Proliferation in Vitro. CFSE-labeled TCR Tg CD4 T cells were cultured in vitro with either mDCs or pDCs from different sources. The T-cell/DC ratio was 20/1, in complete medium + 10% (vol/vol) heat-inactivated FBS for 84 h at 37°C. For PD-L1 blockade experiments, a concentration of 0.20 μg/mL was added.
Microchimerism Analysis-qPCR. qPCR with HD d primers were performed as described in ref. 23 , and the number of copies was estimated based on Cq values.
Antigen Acquisition in Vitro Cell Culture with EVs. Splenocytes were cultured with EVs. A total of 0.5 × 10 6 splenocytes + standardized amount of EV (50 μg of total EV-derived proteins) in Complete medium + 10% exosome-free FBS (SBI SystemBiosciences, no. EXO-FBS-50A-1) were cultured at 37°C.
Western Blot and ELISA. Western blots and ELISAs were performed by following standard procedures (see details in SI Materials and Methods).
Statistical Analysis. Statistical significance was estimated by using Student's t, the Mann-Whitney U test, χ 2 , and Pearson r, when appropriate, with α = 0.05.
